A Comparison of Tc 99m Tilmanocept Quantitative Imaging With Immunohistochemical (IHC) Analysis of CD206 Expression in Synovial Tissue From Subjects Clinically Diagnosed With Rheumatoid Arthritis (RA)
Latest Information Update: 10 Jan 2025
At a glance
- Drugs Tc 99m tilmanocept (Primary) ; Tc 99m tilmanocept (Primary)
- Indications Rheumatoid arthritis
- Focus Diagnostic use
- Sponsors Navidea Biopharmaceuticals
Most Recent Events
- 25 Jul 2024 Status changed from recruiting to discontinued.
- 23 Apr 2024 Planned End Date changed from 1 Sep 2023 to 31 Dec 2024.
- 23 Apr 2024 Planned primary completion date changed from 1 Jun 2023 to 31 Dec 2024.